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Nonviral delivery system receives attention over the last decade. Chitosan (CS) is a cationic polymer whereas saponin (SP) is
classified as glycoside. In this study, a spherically-shaped CS-SP nanoparticle was synthesized and characterized. The ability of the
nanoparticle to protect DNA from enzymatic degradation, its thermostability and cytotoxicity were evaluated.The particle size was
found below 100 nm as determined by Zetasizer, transmission electron microscopy (TEM), and field scanning electron microscopy
(FSEM) results.The surface charge ranges from 43.7mV to 38.5mV before and after encapsulation with DNA plasmid, respectively.
In terms of thermostability, Thermal Gravimetric Analysis (TGA) and Differential Scanning Calorimetry (DSC) revealed that CS-
SP nanoparticle had a melting temperature of 110∘C, with rapid decomposition occurring at 120∘C. Encapsulation of DNA with the
synthesized nanoparticle was evidenced by changes in the FTIR spectra including characteristic peaks at 3267.39 and 1635.58 cm−1,
wavenumbers. Additional peak was also observed at 1169.7 cm−1 following encapsulation. Electrophoretic mobility showed that
CS-SP nanoparticle protected plasmid DNA from enzymatic degradation, while cell viability assays confirmed that the synthesized
nanoparticle exhibited low cytotoxicity at different concentrations in avian cells. Taken together these, CS-SP nanoparticle showed
potentials for applications as a DNA delivery system.
1. Introduction
DNA vaccines are getting considerable attention for use as
alternatives in human and veterinary medicines. DNA vac-
cines are relatively safe and fast to produce andhave the ability
to stimulate the desired immune responses [1–3]. However,
potential limitations, including degradation by endonuclease
enzymes in vivo, effect of pH, and low immune response,
have hindered their applications in field situation [1, 4, 5].
Thus, there is a growing need to improve their effectiveness
in terms of delivery and sustained antigen release [6]. Recent
advances in material sciences and nanotechnology allowed
significant progress in the use of nonviral vectors for effective
gene delivery [7]. Apart from their ability to carry large
genes, nonviral vectors are less toxic, making them safe as
compared to viral-vector systems [8, 9]. Several cationic
polymers such as chitosan have been used as biodegradable
nanomaterials for gene delivery [7]. Chitosan is a polycationic
polysaccharide derived from crustacean as well as insects
[10, 11]. On the other hand, saponin is a naturally occurring
glycoside, with the ability to form stable soap-like foams in
aqueous solutions. The amphiphilic nature of saponin com-
pounds allows them to carry different antigens or protein for
delivery into the cells and also serves as immunomodulators
[12]. The aim of this study is to synthesize and characterize
a chitosan-saponin (CS-SP) nanoparticle for application in
plasmid DNA delivery.
2. Materials and Methods
2.1. Synthesis of Chitosan-Saponin Nanoparticles. A 1% chi-
tosan (75%–85% deacetylated) solution (Sigma-Aldrich,
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USA) was prepared by dissolving 0.1 g of chitosan in 10mL
distilledwater containing 100𝜇L acetic acid (Fisher Scientific,
Malaysia).The dissolved mixture was vigorously vortexed for
5min, sonicated for 30min, and centrifuged at low speed
to remove air bubbles. The pH of the solution was adjusted
to 5.5 by adding 0.1M sodium hydroxide (Sigma-Aldrich,
USA) while continuously stirring as described by Mao et al.
[7]. Similarly, about 0.1 g of saponin (Sigma-Aldrich, USA)
was dissolved in 10mL of miliQ water (Merk Millipore,
Germany) and filtered in 0.22 𝜇m filter. To prepare a CS-SP
nanoparticle, chitosan (0.03%) and saponin (0.001%) were
mixed and stirred for 5min at 500 rpm.The pH of the CS-SP
mixture was further adjusted to 5.5 and then filtered through
0.22𝜇m syringe filter (Sartorius, Germany).
2.2. Preparation of Chitosan-Saponin Encapsulated DNA Plas-
mid. A bivalent IB DNA plasmid designated pBudCR88-
S1/M41-S1 was encapsulated with a CS-SP nanoparticle to
obtain pBudCR88-S1/M41-nanoparticle. Encapsulation was
achieved by separate heating of the DNA plasmid as well
as CS-SP mixtures at 55∘C followed by immediate mixing
of both plasmid DNA and CS-SP in a single tube and brief
vortexing. Final mixture of CS-SP-DNA was obtained at a
ratio of 3 : 1 : 1 respectively.
2.3. Characterization of Chitosan-Saponin Nanoparticle
2.3.1. Transmission Electron Microscopy. The morphology of
the synthesized nanoparticle was evaluated by transmission
electron microscopy (TEM) using Hitachi H-7100 (Hitachi,
Japan). Briefly, a drop of nanoparticle suspension was placed
on a parafilm and a carbon coated grid (Agar Scientific, UK)
was floated on the nanoparticle drop and kept for 5min, then,
and fixed in 2% phosphotungstic acid (PTA) (Sigma, USA)
for another 5min.The grid was removed to blot excess liquid
and dropped over a Whatman paper (GE Healthcare, UK) in
a Petri dish. The grid was further dried in a desiccator and
viewed under electron microscope (Hitachi, Japan) [13].
2.3.2. Field Scanning Electron Microscopy. Field scanning
electron microscopy (FSEM) was used to determine the
surface morphology of CS-SP nanoparticle. A drop of CS-SP
nanoparticle suspension was placed on a curved aluminum
foil and allowed to dry under a beam of light before coating
with gold and subsequent viewing under FSEM (JEOL-7600F,
USA).
2.3.3. Analysis of Zeta Size and Potentials. The prepared
nanoparticle was subjected to zeta size and zeta potential
measurements using a dynamic laser light scattering method
in aMalvern zeta instrument 3000 (Malvern Instrument,UK)
as described previously [7]. Briefly, about 100 𝜇Lof the sample
was resuspended in 900𝜇L miliQ water and added to the
cuvette. Measurement was carried out in a temperature of
25∘C and a scattering angle of 90∘C. Material dispersion and
refractive indexes were set at 1.365 and 1.330 (viscosity (CP)
0.8872) while dielectric constant was 78.5, respectively [14].
2.3.4. Fourier Transform Infrared Spectroscopy. Fourier trans-
form infrared spectroscopy (FTIR) spectra of the CS-SP
encapsulated DNA were evaluated on Nicolet iS 50 FT-IR
Spectrometer FTIR-Nexus (Thermo Fisher Scientific Inc.,
Waltham, MA, USA).
2.3.5. Thermal Gravimetric Analysis. Changes in the thermal
properties of nanoparticle were determined using thermo-
gravimetric analyzer, model TGA/SDTA85e (Mettler Toledo,
Switzerland). Briefly, about 200 𝜇L of sample was placed in
a previously tarred stainless-steel pan and heated from 25∘C
to 250∘C at the rate of 10∘C/min under nitrogen supply of
10mL/min.
2.3.6. Differential Scanning Calorimetry. Differential scan-
ning calorimetric analysis was carried out using DSC 823e
(Mettler Toledo, Switzerland). About 200𝜇L of the sample
was heated from 25∘C to 300∘C at the rate of 10∘C per minute
under nitrogen gas carrier supplied at 10mL/min.
2.3.7. Protection against Enzymatic Degradation. To deter-
mine whether CS-SP nanoparticle is able to protect plasmid
DNA against enzymatic degradation, the CS-SP encapsu-
lated DNA plasmids as well as naked DNA plasmids were
digested with DNASE1 enzymes at 1 U/𝜇g DNA. The CS-SP
encapsulated DNA sample was also treated with chitosanase
enzymes to serve as control. For DNASE1 digestion, samples
were incubated at 37∘C for 30min following digestion and the
reaction was terminated with a stop solution. All mixtures
were analyzed for electrophoreticmobility in 0.8% agarose gel
(FirstBase, Selangor,Malaysia) (BioRad,Hercules, CA,USA).
2.3.8. Cytotoxicity by MTT Assay. Cytotoxicity assay was
carried out using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide solution (MTT) dye reduction reagent
(Sigma-Aldrich, USA) as described previously [15]. A 96-
well plate was seeded with DF1 cells at 105 cells/mL. The
cells were grown in 50𝜇L, DMEMmedia supplemented with
10% fetal bovine serum. Cells were incubated at 37∘C for
24 hrs under humidified 5% CO
2
. When the cells reached
70–80% confluence, media were discarded and washed twice
with 1X phosphate buffer saline (PBS) (pH 7.4). The cells
were then treated with various concentrations of nanopar-
ticle. Negative control cells were kept untreated; however,
Dulbecco’s Modified Eagle’s Medium (DMEM) was added
as mock-treatment. Both treated and control cells were fur-
ther incubated overnight for 24 hrs under similar condition
described in this section. After 24 hours of incubation, cells
were washed twice with 1X PBS followed by addition of MTT
reagent at a concentration of 0.2–0.5mg/mL to each well.
Further incubation was carried out for 3 hrs under 5% CO
2
condition. In order to stop the reaction, about 100𝜇L of
dimethyl sulfoxide (DMSO) (Sigma-Aldrich) was added to
each well for solubilization and the plates were incubated for
30min before checking for absorbance at 570 nm in TECAN
sunrise microplate reader (TECAN, Switzerland). Optical
densities of treated cells were compared with that of neg-
ative control cells and percentage viability was determined
Journal of Nanomaterials 3
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Figure 1: Size distribution of CS-SP nanoparticle as revealed by
Malvern Zetasizer.
as absorbance of treated/absorbance of control × 100 and
expressed in percentage.
3. Results
3.1. Synthesis of Chitosan-Saponin Nanoparticles. To obtain a
nanoparticle suspension, various approaches such as vortex-
ing, sonication, pH adjustment, and dilutions were carried
out. Optimum size was achieved by premixing for 15–20 sec,
followed by sonication for 15min.The pH of the mixture was
adjusted to 5.5 for maximum chitosan effects. A final mixture
of the complexes nanoparticle was achieved by adding 300 𝜇g
(0.03%) chitosan, 100 𝜇g saponin, and 100 𝜇g plasmidDNA at
a ratio of 3 : 1 : 1.
3.2. Analysis of Zeta Size. Since particle size is known to affect
the interaction and uptake of a nanomaterial at the mucosa
level [16], the size distribution of synthesized nanoparticle
was evaluated using a Malvern Zetasizer. Mean nanoparticle
size for CS-SP was found below 100 nm with a distribution of
70.67 nm (Figure 1).
3.3. Analysis of Zeta Potential. Determination of zeta poten-
tial was carried out to understand the charges as well as
particle stability. Zeta potential for CS-SP nanoparticle was
found to be 43.7mV (Figure 2(a)). However, the particle
surface charge decreases to 38.5mV when negatively charged
DNA plasmid was added into the mixture (Figure 2(b)).
3.4. Analysis of Nanoparticle Size by TEM. Results from
TEM analysis revealed spherically shaped CS-SP nanoparti-
cle (Figures 3(a) and 3(b)) with sizes ranging from 33.72 nm
to 54 nm before complexion (a) and up to 79.37 nm after
complexion (b), thus supporting the Zetasizer measurement
result. The prepared nanoparticle was relatively homogenous
in nature though some particles tend to agglomerate after
encapsulation with DNA plasmid (Figures 3(a) and 3(b)).
3.5. Morphological Analysis by SEM. As in TEM, analysis of
surface morphology by FSEM revealed that the synthesised
CS-SP nanoparticle was spherical in nature. This is similar to
that observed under TEM (Figure 4).
3.6. Fourier Transform Infrared Spectroscopy. Fourier trans-
form infrared spectroscopy showed presence of characteristic
peaks at 3239.27, 1635.31, and 1279.03 cm−1 chitosan molecule
(Figure 5(a)). In the case of saponin, major peaks appeared at
3250.97 and 1635.18 cm−1 (Figure 5(b)). There was a shift in
the chitosan peaks after interaction with saponin molecule as
evident by characteristic peaks at 3249.09 and 1279.95 cm−1
(Figure 5(c)). On the other hand, following complexion of
CS-SP nanoparticle with plasmid DNA, peaks at 3249.04 and
1635.09 cm−1 shifted from lower frequency wavenumbers to
a high frequency wavenumbers as 3267.39 and 1635.58 cm−1,
respectively. Additional peak was observed at position 1169.7
following encapsulation with DNA plasmid (Figure 5(d)).
3.7. Thermal Gravimetric Analysis. Chitosan-nanosaponin
recorded a sharp degradation at a temperature of about
110∘C, thus indicating its melting temperature. There was an
observable weight loss occurring from a temperature of 135∘C
to 280∘C leaving only about 2.3% remnant of the total product
(Figures 6(a) and 6(b)).
3.8. Differential Scanning Calorimetry. The glass transition
temperature of the CS-SP nanoparticle was found to be
55.78∘C and its stability reached 120∘C, thus suggesting the
optimum thermal stability of the product as shown in its
endothermic peak (Figure 6(b)).
3.9. Protection against Enzymatic Degradation. The protec-
tive efficacy of CS-SP against enzymatic degradation was
evaluated following treatment of encapsulatedDNAplasmids
with DNASE1 enzyme. The result indicates complete pro-
tection of the CS-SP encapsulated DNA as evident by the
absence of DNA mobility in lanes 3 and 5, respectively. In
contrast, DNA mobility was evident in CS-SP encapsulated
DNA treated with chitosanase enzymes which removes chi-
tosan (lane 6). Naked DNA group treated with DNASE1 did
not show evidence of DNA band since the enzymes already
degraded the unprotected DNA plasmid (Figure 7).
3.10. Cytotoxicity Assay. Percentage cell viability was used
to determine the toxicity of CS, SP and CS-SP nanopar-
ticle in chicken secondary fibroblast cells (DF1). Various
concentrations ranging from 2500mg/mL to 0.008mg/mL
were used. Chitosan was shown to be less toxic having cell
viability of more than 50% even at 500mg/mL concentration.
On the other hand saponin was only nontoxic at 4mg/mL
concentration. Combination of chitosan and saponin in the
nanoparticle led to a drastic reduction in the toxicity of
saponin; thus, treatment with chitosan-nanosaponin resulted
in more than 50% cell viability even at a concentration of
100mg/mL (Figure 8).
4. Discussion
There is a growing interest in the use of nonviral vector
as alternatives in gene delivery [17]. In this study, a CS-SP
nanoparticle was synthesized and characterized for possible
use in plasmid DNA vaccine delivery. Preparation of the
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Figure 2: (a) Surface charges of chitosan-saponin nanoparticle before complexion with DNA. (b) Surface charges of CS-SP nanoparticle as
determined by zeta potentials.
(a) (b)
Figure 3: Transmission electron microscopy (TEM) showing a spherically shaped CS-SP nanoparticle before (a) and after (b) encapsulation
with DNA plasmid. Bar = 100 nm.
Figure 4: Surface morphology of CS-SP nanoparticle as revealed by
field scanning electron microscopy (FSEM). Bar = 100 nm.
nanomaterial was achieved through adjustment of param-
eters such as pH as reported in previous studies [7, 15].
Apart from the ability of the chitosan to deliver vaccine
antigen, the incorporated saponin has the advantage of acting
as adjuvant or an immunomodulatory molecule to enhance
immune response. This property was reported in saponin
or ISCOM-based antigens [18–20]. Thus incorporation of
saponin in this study might boost immune response in an in
vivo system.
The synthesized nanoparticle was found within the nano
range as evident by the zeta sizer result result and corrobo-
rated by TEM and SEM analyses. Interestingly, the size and
particle morphology observed in this study are consistent
with previous reports [15]. However, some studies reported
large sizes of particle ranging from 170 to 580 nm. This
variation could be as a result of the preparationmethods, pH,
and nature of startingmaterials used to synthesize the particle
[21, 22]. Studies have also shown than a smaller particle of
less than 10 𝜇m is usually phagocytized by antigen presenting
cells such as macrophages and dendritic cells, thus favoring
the presentation of vaccine antigen [23].
The overall surface charges for CS-SP nanoparticle
remained high, despite addition of a negatively charged DNA
containing phosphate group. The strong positive charges are
likely associated with chitosan, which is known to possess
high positive charges at a pH of about 5-6 due to of
protonation of amino group NH3
+ in the presence of acetic
acid medium. Other studies reported strong positive surface
Journal of Nanomaterials 5
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Figure 5: Fourier transform infrared spectra of chitosan (a), saponin (b), chitosan-saponin nanoparticle (c), and chitosan-saponin-DNA
complexion (d).
charges in chitosan as well [24]. Adjustment of pH was
similarly reported to affect the charges since NaOH may
form the source of a hydroxyl group which may interact with
protons (H+) of the amine group in chitosan, thus rendering
it deprotonated [25].
Changes in the FTIR peaks observed at 3239.27, 1635.31,
and 1279.03 cm−1 positions in the chitosan compound
are likely associated with primary amine (-NH2), amide
(-CONH2), and aromatic amine (C-N), respectively, present
in chitosan. Similar result has been observed in other studies
[15, 22]. On the other hand, major peaks occurring at 3250.97
and 1635.18 cm−1 in saponin compound might indicate a
broad and strong stretching vibration resulting from hydro-
gen bonding (O-H) as well as a medium stretching due to
secondary carbon (C=C) bonding, respectively [15].
Interaction of chitosan with saponin might have caused
some peaks located at 3239.27 and 1279.03 cm−1 to shift from
lower frequency wavenumbers to high frequency wavenum-
bers as indicated in 3249.09 and 1279.95 cm−1, respectively.
Similarly, peak at 1635.31 cm−1 was observed to shift from
high to a lower frequency wavenumber as 1635.09 cm−1 in
CS-SP nanoparticle.This may suggest hydrogen but not ionic
interaction between the two compounds [15].
Increase in frequency of CS-SP peaks at 3267.39 and
1635.58 cm−1 in addition to the absence of signature peak
at 1279.95 cm as well as appearance of new peak at posi-
tion 1169.7 cm−1 also indicates interaction between CS-SP
nanoparticle and the DNA compound. Evidently, the later
peak indicates a stretching vibration probably due to phos-
phate group (P=O) and ester bonding in the DNAmolecules.
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Figure 6: (a) Thermogravimetric analysis, curve showing melting temperature and % residue left following heating of chitosan-saponin
nanoparticle. (b) Thermal stability of chitosan-saponin nanoparticle as revealed by differential scanning calorimetry.
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Figure 7: Protective capacity of CS-SP nanoparticle against enzy-
matic degradation of DNA plasmid. Lane 1: 1 kb ladder (Viventis,
Malaysia); lane 2: naked untreated DNA; lane 3: CS-SP-DNA with-
out enzymatic treatment; lane 4: naked DNA treated with DNASE1;
lane 5: CS-DNA-SP treated with DNASE1; lane 6: CS-SP-DNA
treated with chitosanase which removes the chitosan protection and
exposes the DNA plasmid.
This may result from competitive displacement following
encapsulation of the DNA [26].
In the thermal study, both TGA and DSC analyses
confirmed that CS-SP DNA nanoparticle is thermostable,
thus suggesting its potential application in plasmid vaccines
used in a field situation. However, other studies have reported
a much highly stable compound able to resist a temperature
of 500∘C [15].The variation could be associatedwith disparity
in water content between the two mixtures. It is expected
that rapid weight loss may occur as a result of dehydration
of the anhydrous glycosidic ring [27]. In addition, the use
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Figure 8: Determination of cell viability by MTT assay following
treatment of DF1 cells with different concentrations of CS, SP, and
CS-SP-DNA nanoparticle.
of tripolyphosphate (TPP) in Rejinold et al. [15] might have
causedmodification in the crystalline nature of both chitosan
and saponin, thus making the two molecules more stable on
heating. Other studies have also reported a good stability in
either chitosan alone, as CS-SP, or in combination with other
compounds [15, 21, 26].
Enzymatic degradation has been the major concern in
plasmid DNA delivery [28]. In this study, encapsulation
of plasmid DNA with CS-SP nanoparticle was shown to
protect DNA from enzymatic degradation. This is thought
to be majorly associated with a highly positive charged
chitosan, surrounding both saponin and DNA molecules.
In contrast, naked unprotected plasmid was shown to be
degraded following enzymatic digestion.These findings agree
with other reports demonstrating the ability of chitosan
derived nanoparticle to protect DNA from DNASE1 enzyme
in vitro [21, 29, 30].
In terms of toxicity, both CS and CS-SP nanoparticles
were shown to be nontoxic at relatively high concentrations;
in contrast, saponin was found to be toxic at a relatively high
concentration. Several studies have reported the nontoxic
Journal of Nanomaterials 7
nature of chitosan in various cells, though most studies used
a non-avian cell model [7, 21]. On the other hand, saponin
alone or in combination with other molecules was reported
to exhibit selective cytotoxicity in cancer cells and nontoxic at
low concentration in normal cos-7, vero, L929, and NIH-3T3
cells [12, 15]. This suggests its addition as immunomodulator
in a delivery system [22].
5. Conclusion
In this study, a CS-SP nanoparticle was synthesized and char-
acterized. Based on the size, morphology, thermostability,
protection againstDNASE1 digestion, and cytotoxicity assays,
it could be concluded that CS-SP nanoparticle has potentials
for biological application as DNA delivery system.
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